Tyrphostin AG490, a tyrosine kinase inhibitor, blocks actively induced experimental autoimmune encephalomyelitis

European Journal of Immunology

Volumn 28, Issue 11, 1998, Pages 3523-3529

  Constantin, Gabriela ^a,b,c   Brocke, Stefan ^d   Izikson, Allan ^d   Laudanna, Carlo ^c   Butcher, Eugene C ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^c UNIVERSITY OF VERONA   (Italy)

^d NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

Adhesion; Encephalomyelitis; Lymphocyte; Tyrosine kinase

Indexed keywords

FIBRONECTIN; PROTEIN TYROSINE KINASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA; TYRPHOSTIN; VASCULAR CELL ADHESION MOLECULE 1;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; IMMUNOSTIMULATION; LEUKOCYTE; LYMPHOCYTE MIGRATION; LYMPHOCYTE PROLIFERATION; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PARALYSIS; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; CELL ADHESION; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ENZYME INHIBITORS; FEMALE; INTERFERON TYPE II; INTERLEUKIN-10; LEUKOCYTES; MICE; PROTEIN-TYROSINE KINASES; TYRPHOSTINS;

EID: 0031768521     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199811)28:11<3523::AID-IMMU3523>3.0.CO;2-X     Document Type: Article

References (33)

1. Sloan, D. J., Wood, M. J. and Charlton, H. M., Leukocytes recruitment and inflammation in the CNS. Trends Neurosci. 1992. 15: 276-278.
2. Yednock, T., Cannon, C., Fritz, L. C., Sanchez-Madrid, F., Steinman, L. and Karin, N., Prevention of experimental autoimmune encephalomyelitis by antibodies against α4β1 integrin. Nature 1992. 356: 63-66.
3. Steffen, B. J., Butcher, E. C. and Engelhardt, B., Evidence for involvement of ICAM-1 and VCAM-1 in lymphocyte interaction with endothelium in experimental autoimmune encephalomyelitis in the central nervous system in the SJL/J mouse. Am. J. Pathol. 1994. 145: 189-201.
4. Merrill, J. E. and Benviste, E. N., Cytokines in inflammatory brain lesions: helpful and harmful. Trends Neurosci. 1996. 19: 331-338.
5. Levitzki, A. and Gazit, A., Tyrosine kinase inhibition: an approach to drug development. Science 1995. 267: 1782-1787.
6. Meydan, N., Grungerber, T, Dadi, H., Shahar, M., Arpaia, E., Lapidot, Z., Leeder, J. S., Freedman, M., Cohen, A., Gazit, A., Levitzki, A. and Roifman, C. M., Inhibition of acute lymphoblastic leukemia by a Jak-2 inhibitor. Nature 1996. 379: 645-648.
7. Novogrodsky, A., Vanichkin, A., Patya, M., Gazit, A., Osherov, N. and Levitzki, A., Prevention of lipopolysaccharide-induced lethal toxicity by tyrosine kinase inhibitors. Science 1994. 264: 1319-1322.
8. Powis, G., Signalling pathways as targets for anticancer drug development. Pharmacol. Ther. 1994. 62: 57-95.
9. Levitzki, A., Tyrphostins-potential antiproliferative agents and novel molecular tools. Biochem. Pharmacol. 1990. 40: 913-918.
10. Levitzki, A., Signal transduction therapy - A novel approach to disease management. Eur. J. Biochem. 1994. 226: 1-13.
11. Sung, K. L., Yang, L., Elices, M., Jin, G., Sriramarao, P. and Broide, D. H., Granulocyte-Macrophage Colony-Stimulating Factor regulates the functional adhesive state of VLA-4 expressed by eosinophils. J. Immunol. 1997. 158: 919-927.
12. Levesque, J. P., Leavesley, D. I., Niutta, S., Vadas, M. and Simmons, P. J., Cytokines increase human hemopoietic cell adhesiveness by activation of very late antigen VLA-4 and VLA-5. J. Exp. Med. 1995. 181: 1805-1815.
13. Chan, A. C., Desai, D. M. and Weiss, A., The role of protein tyrosine kinases and protein tyrosine phosphatases in T cell antigen receptor signal transduction. Annu. Rev. Immunol. 1994. 12: 555-592.
14. Olsson, T., Critical influences of the cytokine orchestration on the outcome of myelin antigen-specific T cell autoimmunity on EAE and MS. Immunol. Rev. 1995. 144: 245-251.
15. Billiau, A., Heremans, H., Vandekerckhove, R, Dijkmans, R., Sobis, H., Meulepas, E. and Carton, H., Enhancement of experimental allergic encephalomyelitis by antibodies against IFN-gamma. J. Immunol. 1988. 140: 1506-1516.
16. Duong, T. T., St. Louis, J., Gilbert, J. J., Finkelman, F. D. and Strejan, G. H., Effect of anti-interferon-gamma and anti-interleukin 2 monoclonal antibody treatment on the development of actively and passively induced experimental allergic encephalomyelitis in the SJL/J mouse. J. Neuroimmunol. 1992. 36: 105-115.
17. Lublin, F. D., Knobler, R. L., Kalman, B., Goldhaber, M., Marini, J., Perrault, M., D'Imperio, C., Joseph, J., Alkan, S. S. and Korngold, R., Monoclonal anti-gamma interferon antibodies enhance experimental allergic encephalomyelitis. Autoimmunity 1993. 16: 267-274.
18. Voorthuis, J. A., Uitdehaag, B. M., De Groot, C. J., Goede, P. H., van der Meide, P. H. and Dijkstra, C. D., Suppression of EAE by intraventricular administration of IFN-γ in Lewis rats. Clin. Exp. Immunol. 1990. 81: 183-188.
19. Willenborg, D. O., Fordham, S., Bernard, C. C. A., Cowden, W. B. and Ramshaw, I. A., IFN-γ plays a critical down-regulatory role in the induction and effector phase of MOG-induced autoimmune encephalomyelitis. J. Immunol. 1996. 157: 3223-3227.
20. Krakowski, M. and Owens, T., Interferon-γ confers resistance to experimental allergic encephalomyelitis. Eur. J. Immunol. 1996. 26: 1641-1646.
21. Geissler, K., Current status of clinical development of IL-10. Curr. Opin. Hematol. 1996. 3: 203-208.
22. Krakauer, T., IL-10 inhibits the adhesion of leukocytic cells to IL-1-activated human endothelial cells. Immunol. Lett. 1995. 45: 61-65
23. Clinchy, B., Bjork, P., Paulie, S. and Moller, G., IL-10 inhibits motility in murine and human B lymphocytes. Immunology 1994. 82: 376-382.
24. Cannella, B., Gao, Y. L. and Raine, C. S., IL-10 fails to abrogate experimental autoimmune encephalomyelitis. J. Neurosci. Res. 1996. 46: 735-746.
25. Nagelkerken, L., Blauw, B. and Tielemans, M., II-4 abrogates the inhibitory effect of IL-10 on the development of EAE in SJL mice. Int. Immunol. 1997. 9: 1243-1251.
26. Rott, O., Fleischer, B. and Cash. E., Interleukin-10 prevents EAE in rats. Eur. J. Immunol. 1994. 24: 1434-1440.
27. Xiao, B. G., Bai, X. F., Zhang, G. X. and Link, H., Suppression of acute and protracted-relapsing EAE by nasal administration of low-dose IL-10 in rats. J. Neuroimmunol. 1998. 84: 230-237.
28. Cua, D. J., Coffman, R. L. and Stohlman, S. A., Exposure to Th2 cytokines in vivo before encounter with antigen selects for T helper subsets via alterations in antigen-presentation cell function. J. Immunol. 1996. 157: 2830-2836.
29. Mathisen, P. M., Yu, M., Johnson, J. M., Drazba, J. A. and Tuohy, V. H., Treatment of EAE with genetically modified memory T cells. J. Exp. Med. 1997. 186: 159-164.
30. Groux, H., O'Garra, A., Bigler, M., Rouleau, M., Antonenko, S., de Vries, J. E. and Roncarolo, M. G., A CD4+ T cell subset inhibits antigen-specific T cell responses and prevents colitis. Nature 1997. 389: 737-742.
31. Brocke, S., Gijbels, K. and Steinman, L, Experimental autoimmune encephalomyelitis in the mouse. In Cohen, I. R. and Miller, A. (Eds.) Autoimmune disease models. Academic Press, San Diego, 1994, pp. 1-14.
32. 3H]glycerol labeling. J. Immunol. Methods 1997. 203: 35-44.
33. Laudanna, C., Campbell, J. J. and Butscher, E. C., Role of Rho in chemoattractant-activated leukocyte adhesion through integrins. Science 1996. 271: 981-983.